Nephraegis Therapeutics
Lake Forest, Illinois, United States
About Nephraegis Therapeutics
Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (May 2021)
- Website: nephraegis.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/nephraegis-therapeutics-2573192 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.